ABSTRACT-Military experience and recent in vitro laboratory data provide a biological rationale for whole-blood use in the treatment of exsanguinating hemorrhage and have renewed interest in the reintroduction of fresh whole blood and coldstored whole blood to patient care in austere environments. There is scant evidence to support, in a field environment, that a whole bloodYbased resuscitation strategy is superior to a crystalloid/colloid approach even when augmented by a limited number of red blood cell (RBC) and plasma units. Recent retrospective evidence suggests that, in this setting, resuscitation with a full compliment of RBCs, plasma, and platelets may offer an advantage, especially under conditions where evacuation is delayed. No current evacuation system, military or civilian, is capable of providing RBC, plasma, and platelet units in a prehospital environment, especially in austere settings. As a result, for the vast minority of casualties, in austere settings, with life-threatening hemorrhage, it is appropriate to consider a whole bloodYbased resuscitation approach to provide a balanced response to altered hemostasis and oxygen debt, with the goal of reducing the risk of death from hemorrhagic shock. To optimize the successful use of fresh whole blood/cold-stored whole blood in combat field environments, proper planning and frequent training to maximize efficiency and safety will be required. Combat medics will need proper protocol-based guidance and education if whole-blood collection and transfusion are to be successfully and safely performed in austere environments. In this article, we present the Norwegian Naval Special Operation Commando unitYspecific remote damage control resuscitation protocol, which includes field collection and transfusion of whole blood. This protocol can serve as a template for others to use and adjust for their own military or civilian unitYspecific needs and capabilities for care in austere environments.
INTRODUCTION
Most deaths on the battlefield today are nonsurvivable, defined as Bno measure taken will save the life of the severely wounded soldier[ (1). However, among the group of potentially salvageable fatalities, hemorrhage is the leading cause of death (2) . The resuscitation of patients with traumatic hemorrhagic shock has changed toward a model known as Bdamage control resuscitation[ (DCR) (3) . The application of DCR in the prehospital setting is termed Bremote damage control resuscitation[ (RDCR) (4) . Therapeutic options applied in RDCR can change as the challenges and timeline to reaching higher echelons of care are increased (e.g., military operations in far-forward locations). Blood components of red blood cell (RBC), plasma, and platelet units in addition to whole blood are used to provide hemostatic resuscitation within the overarching concept of DCR (3) .
When the tactical situation and logistical obstacles do not permit implementation of a blood componentYbased resuscitation strategy for traumatic hemorrhagic shock, an alternative approach is required. This approach must be simple and safe to perform. Because the early treatment of oxygen debt and coagulopathy is important in preventing death from exsanguination, we suggest that the use of whole blood is an appropriate alternative in austere settings where all blood components are not available. Whole blood is perhaps the most appropriate product for hemostatic resuscitation, which is defined as, Bthe early use of a balanced amount of RBCs, plasma, and platelets [ (5) . The challenges to making whole blood available for hemostatic resuscitation in RDCR are to develop feasible and safe Bcollection-and-use[ protocols.
Historical reports on the use of whole blood in World War II and Vietnam show that it was the preferred resuscitation product compared with the use of individual blood components such as plasma (6, 7) . Over time, blood product availability shifted from whole blood to individual components in an effort to conserve blood as a resource and provide single blood components for specific deficiencies (anemia, thrombocytopenia, etc.). This resulted in the elimination of whole blood as a blood product that was available for patients with severe bleeding, except in very limited circumstances such as pediatric cardiac surgery. Recent military experience and in vitro laboratory data provide a biological rationale for whole-blood use in the treatment of exsanguinating hemorrhage and have renewed interest in the reintroduction of warm whole blood (WWB) stored at 22-C for less than 24 h and cold-stored whole blood (CWB) stored at 4-C for as long as 21 days (preferred G10 days of storage) to patient care in austere environments (8, 9) .
Currently, the predominant resuscitation fluids used for patients with exsanguinating injuries in the field are crystalloids and colloids. Uncommonly, RBC and plasma units are available in limited supply. No current evacuation system, military or civilian, is capable of providing RBC, plasma, and platelet units in a prehospital environment. As a result, in austere environments, for casualties with life-threatening hemorrhage, it is appropriate to consider a whole bloodYbased resuscitation approach to provide a balanced response to altered hemostasis and oxygen debt, with the goal of reducing the risk of death from hemorrhagic shock.
Although there is scant evidence to support that a whole bloodYbased resuscitation strategy is superior to a crystalloid/ colloid approach, even when augmented by a limited number of RBC and plasma units, recent retrospective evidence (12, 13) . In addition, an innovative use of buddy transfusion in a unique remote environment has also been established for the treatment of nontraumatic hemorrhagic shock on board Royal Caribbean Cruiseliners, where prolonged evacuation times (96 h) to land-based medical treatment facilities are typical. Because critical bleeding events are uncommon in this setting, it would be prohibitively costly to maintain on-board stores of components and almost impossible to anticipate blood product needs. Within a 3-year period, 37 patients with hemorrhagic shock have been transfused with whole blood collected Bon scene[ for life-threatening hemorrhagic shock, most commonly as a result of gastrointestinal bleeding, while aboard Royal Caribbean Cruiseliners (14) . The criterion for WWB transfusion by Royal Caribbean Cruiseliner providers is hemodynamic instability in the presence of hemorrhage, with relative anemia. This has been a successful program because of proper planning and frequent medical staff training to maximize efficiency and safety. To optimize successful use of WWB/CWB in combat field environments, a similar approach will be required. Combat medics will need proper protocol-based guidance, education, and training if whole-blood collection and transfusion are to be successfully performed far forward, when evacuation to military treatment facilities is delayed.
In this article, we present the Norwegian Naval Special Operation Commando unitYspecific RDCR protocol, which includes field collection and transfusion of whole blood. This protocol can be a template for others to use and adjust for their own military or civilian unitYspecific needs and capabilities for care in austere environments.
NORWEGIAN NAVAL SPECIAL OPERATION COMMANDO RDCR PROTOCOL FOR WHOLE BLOOD
This protocol explains in detail the procedures to follow for collecting and administering whole blood in austere environments. The overall purpose and goal are to provide the best treatment possible for the wounded soldier in the safest and most effective way. One must never forget that there are several pitfalls in the administration of whole blood; therefore, it is imperative to follow this protocol when in need of a whole-blood transfusion on the battlefield.
In this protocol, the term Bwarm whole blood[ is used when the blood is maintained at 22-C to 26-C after donation. If the donated blood is cooled to 2-C to 6-C, it is referred to as Bcold-stored whole blood.[ Whole blood stored for less than 48 h is referred to as Bfresh.[ All other blood products, such as platelets, plasma, or packed RBCs, are referred to as blood components. Quick reference and standardized equipment lists for the NORVASC RDCR protocol are displayed in Figures 2 and 3. The equipment list is a current list of devices and not an endorsement of any specific product or company. It is simply the equipment being used at the moment. This list is subject to change. The clinically relevant Frequently Asked Questions(FAQ) are highlighted in Figure 4 .
leukoreduced whole blood (in citrate phosphate dextrose [CPD]) can be stored for 21 days. Based on current literature, the in vitro hemostatic properties are well preserved for at least 10 days, so it is preferable to use stored whole blood within this time frame (9, 15) . Older units (up to 21 days) will have reduced function of RBCs, plasma coagulation factors, and platelets but would still be preferred to a crystalloid-based resuscitation for patients with life-threatening hemorrhage. Whole-blood storage temperature should be monitored continuously. If the cold chain has been compromised, there is an increased risk of bacterial contamination. These CWB units should not be used unless there is no other option for a casualty at immediate risk of death.
Blood safety
To establish this protocol and to have whole blood available as a far-forward resuscitation option, several precautions and preparations must be implemented.
Preparations-All unit personnel must attend a 1-day training program. This program emphasizes the importance of only using whole blood as a measure when it is truly needed (life-threatening hemorrhagic shock). It emphasizes the importance of blood typing and knowing one's own blood type. In general, it spreads awareness of this procedure and its possible complications. Combat medics must attend a 1-week training program. Unit-specific programs are recommended. Units should consider refresher training on a routine basis (at least twice a year) because this technique is a perishable skill.
Screening-All personnel must be screened according to national safety standards for the detection of transfusiontransmittable diseases (TTDs), such as hepatitis B and C and HIV. Personnel ABO blood type must be analyzed by a certified laboratory routinely performing these tests. As an inherent part of the blood type, persons with blood type O have in their plasma so-called regular blood type antibodies, anti-A and anti-B. The levels of these antibodies may vary and, if in high levels, may adversely interact with recipients of type O blood. A certified blood type laboratory should determine this level and report it in titers. A titer value is the reciprocal value of the highest dilution of a serum tested for an antibody. Despite the fact that there is no international consensus on the definition of a low titer, neither regarding the method of titration nor regarding the actual value for a low titer, there is a general agreement to, if possible, use type O blood from Blowtiter[ donors for nonYtype O patients or patients where the blood type cannot be confidently determined (16) . As an example, the Swedish military uses the following: A and B antibody titers less than 100 for IgM and 400 for IgG type antibodies. Determination of ABO titers is highly recommended for whole-blood transfusion programs that intend to use of type O to patients other than those who are type O.
Screening of TTDs, anti-A/anti-B titer in blood type O, and ABO type is performed in the predeployment garrison setting and maintained in medical records. Each individual soldier carries a field donor card that includes this information.
When forces are deployed, a repeat test of TTDs and ABO blood type is performed to verify all medical records. In addition, a standard blood donor interview will be performed after entering the combat theater. This approach will be followed by Norwegian Naval Special Operation Commando (NORNAVSOC)
but could be modified to meet specific unit operational security requirements (e.g., a discreet compatibility team chart).
Vaccination-All personnel must undergo the standard vaccination program according to the national standard for deployed personnel.
Procedure-It is important to follow precisely the specific procedures described here to ensure patient safety. The training program emphasizes the importance of identifying the patient's and the donor's blood types with 100% accuracy. Double checking and proper marking of the collection bag are underlined throughout the procedure as important measures to assure which blood type is administered.
Marking-All personnel should carry a field donor card as previously mentioned. The responsible medic will also carry a medical record that indicates the blood types of his/her team members. In the Tactical Operations Center, the same record of all soldiers' blood types should be available to supporting medical staff and commanders. Permanent marking, that is, tattoo, is also an option for all personnel. The precise format of record keeping can be modified to meet specific unit operational security requirements.
Initiation of the RDCR protocol (Fig. 5)
Indication: Clinical judgment that patient is in hemorrhagic shock (some indicators listed below) 1. Mechanism of injury compatible with severe hemorrhage (e.g., penetrating torso injury/traumatic above-knee amputation or visible massive bleeding) 2. Radial pulse greater than 120 beats/min or weak/absence of radial pulse 3. Altered mental status without head injury 4. Where such monitoring is available:
Y Single reading of systolic blood pressure of less than 90 mmHg Y Lactate reading of more than 5 mmol/L Y StO 2 less than 65% (17) Mechanism of injury in combination with 2, 3, or 4 is sufficient to initiate the protocol.
When a casualty presents with signs of hemorrhagic shock, administer 1 g of tranexamic acid and two single units of a universal lyophilized plasma product, if available, before considering whole-blood transfusion. The use of plasma as initial resuscitation is grounded in the analyses of recent experience in treating civilian and combat trauma, which suggests that crystalloid resuscitation contributes to dilatational coagulopathy (18) . Use of lyophilized plasma, the standard of care in World War II, may be less likely to worsen coagulopathy, although a dose of two units will not reverse an established coagulopathy. Outcomes data on the prehospital use of plasma are lacking, although studies sponsored by the US Department of Defense are ongoing. In the interim, an extrapolation from the DCR paradigm of trauma care as widely practiced seems reasonable.
Step-by-step protocol Buddy transfusiona. Identify the patient's blood type. The preferable method of identifying a patient's blood type in prioritized order is: Follow the guidance in Figure 1 and screening procedure above regarding ABO type of the whole blood transfused.
b. After identifying the patient's blood type, find a suitable donor. The donor must be identified by the same principles as the patient's blood type. Give whole-blood type A donors to type A recipients and whole-blood type O donors to all other types (e.g., AB).
c. Every soldier carries one collection bag; first use the patient's bag if it is intact and in-date. The bag should be a single packed blood bag with CPD or CPDA-1 anticoagulant mixture in it. The donor marks the bag clearly with his/her first name, blood type, call sign, and date and time group. This should be done with a marker pen on the white label of the collection bag. The person who will perform the needle puncture and collect the blood reads out what is written on the label and confirms it with the donor. If anything is wrong or poorly written, it must be corrected. d. A venous restriction band is applied on the upper arm of the donor to increase venous pressure; this is kept on during blood collection. A single overhand knot is made but not tightened on the plastic tube from the needle to the blood bag before the venous puncture is done. The donor should preferably be in a sitting position. e. The needle puncture is performed preferably on vena cubiti.
Wash the puncture site with alcohol, hold the needle with bevel up, and puncture the vein in one determined movement. Introduce the needle approximately 10 mm into the vein and secure it. If the puncture is successful, blood will flow into the blood bag. f. During donation, the donor, if able, should drink at least 0.5 L of water, preferably more. If available, a pharmaceuticalgrade oral rehydration solution should be consumed. g. After the needle puncture, keep the blood bag continuously in motion. This is to ensure that the blood and the additive solution are well mixed and to observe that the bag is filling. Hold collection bag in hand if possible to prevent direct contact with extremes of temperature. The bag should be situated at least 20 cm below the puncture site. A small tipping weight with a counterweight of 485 g or a measured paracord around the blood bag can be used to mark when the bag is filled with 450 mL of blood. Underfilling the bag can cause citrate toxicity and overfilling can cause clotting in the bag. In general, the goal is to fill the bag to a minimum volume of about 400 mL (450 mL T 10%). The goal level with acceptable limits can be measured on test bags and premarked on bags carried on operations to facilitate estimation of adequate filling. When the bag is filled, remove the needle from the donor arm, allowing any blood in the line to run into the bag, and tighten the knot on the plastic tube as closely to the bag as is feasible (maximizing all blood and anticoagulant mixing). The responsible medic once again double checks the required blood type with the one marked on the bag. If blood bag is exposed to extremes of cold temperature and is cold to touch, use a blood warmer. If patient is in extremis and a blood warmer is unavailable, use body heat if possible to mitigate cooling and administer blood. h. Use an approved blood transfusion set with a filter in the drip chamber to administer the blood. The administration can be via either intravenous or intraosseous access (gauge is immaterial) (19) . Be cautious when introducing the drip chamber into the blood bag; the blood bag can be damaged and start to leak if done incorrectly. Y-infusion sets are not needed. If using a Y-infusion set, do not spike a normal saline bagVrun whole blood alone. i. Infuse by gravity only (no pressure bag and no squeezing of bag). Hypotensive resuscitation is the standard to strive for when treating hemorrhagic shock. Palpable radial pulse is a marker of roughly 80 mmHg systolic blood pressure. After this is established, the goal is to not raise the pressure too much to avoid Bpopping the clot.[ Quantity and rate of blood administration need to be based on the clinical judgment of the responsible practitioner; hypotensive resuscitation principles are guidelines. Remember that this treatment is only buying time and keeping the patient alive until reaching a definitive treatment site. Things to take into consideration are patient response to treatment, expected time to evacuation, available donors or blood bags, and the tactical situation.
If more than one unit of blood is needed, find another appropriate donor and repeat the procedure. A donor should only donate one unit of whole blood; postdonation performance studies show minimal degradation of capabilities (20) . The consequences of donating two units of whole blood are poorly documented. This decision should only be undertaken after consultation with both the tactical commander and senior medical provider on the ground, with the realization you might be creating another impaired patient. j. If the blood is not used immediately, store at room temperature (22-C Y 26-C) for a maximum of 6 h, then store at 2-C to 6-C. After this procedure, the blood can be used for up to 21 days but is preferably used within 10 days (see Fig. 3 . Premission donated blood). It can be stored at room temperature for up to 24 h (22-C) but should be discarded thereafter. k. The transfusion must be registered according to unit-specific procedures and, it is advisable to keep the blood bag with the patient during transport to the surgical facility as documentation and also to follow up TTD testing after transfusion.
Predonated blood/field blood bank
When it is feasible, a team can be equipped with an amount of leukoreduced predonated blood stored in Golden Hour or equivalent containers at 2-C to 6-C. The donors for this blood are personnel available in the forward operating base who have completed the unit's preparation, screening, and vaccination program and have been included in an established Bwalking blood bank.[ The establishment of a walking blood bank is done after a separate protocol and will not be discussed here. The predonated blood units are valid for 10 days as long as the cold chain is preserved. We recommend using low-titer type O whole blood. a. Identify the patient's blood type.
Follow same steps as in buddy transfusion 5.1a b. Retrieve a blood bag from the Golden Hour container.
Preferably only low-titer type O in the Golden Hour container. c. If a fluid warmer is available, the blood should be warmed before infusion.
Avoid using an improvised system for heating the whole blood.
d. Use an approved blood transfusion set with a filter in the drip chamber to administer the blood.
If the patient needs more than one unit of blood, use the predonated blood bags first. If those are not enough, consider performing a buddy transfusion procedure. Follow the guidance in the Special Considerations (Fig. 1) and Screening Procedures regarding ABO type of the whole blood transfused.
e. If a bag is removed from the container for a short period (G20 min) but not used, put it back in, and if the cold chain is preserved, it can still be used until it expires on day 10 of storage.
Type-specific whole blood versus universal whole-blood type O transfusion
We strongly advise the following rules be followed. c.) In-hospital, type-specific whole-blood transfusion is preferred (the casualty receives whole blood with the same ABO type as him/herself).
In chaotic emergent situations (far-forward locations/ combat), ABO incompatibility is the most feared complication and is potentially fatal. Historically, whole-blood type O has been used in emergency situations to avoid this complication. Risk of hemolytic transfusion reaction in the recipient is reduced by using low-titer whole-blood O. A defined amount of antibodies against blood types A and B in donors with type O is set to define what is low and high titer. There is no international standardization of this titer, and until this has been agreed on, national standards have to be followed regarding what is defined as Blow-titer O.[ If anti-A and anti-B titer is unknown, it is still advisable to use donor type O. Risk of a fatal hemolytic transfusion reaction because of transfusion of high-titer whole-blood type O to nonYtype O recipients is still very low compared with the mortality risk facing casualties in hemorrhagic shock prehospital (16) .
CONCLUSIONS
Military experience and recent in vitro laboratory data provide a biological rationale for whole-blood use in the treatment of exsanguinating hemorrhage and have renewed interest in the reintroduction of WWB and CWB (5, 8, 9) . In austere environments, for casualties with life-threatening hemorrhage, it is appropriate to consider a whole bloodYbased resuscitation approach to provide a balanced response to altered hemostasis and oxygen debt, with the goal of reducing the risk of death from hemorrhagic shock. To optimize the successful use of WWB/CWB in combat field environments, proper planning and frequent training to maximize efficiency and safety will be required. Combat medics will need proper protocol-based guidance, education, and training if whole-blood collection and transfusion are to be successfully performed far forward, when evacuation to military treatment facilities is delayed (Fig. 5) .
